Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients.
Saracino A, Monno L, Tartaglia A, Tinelli C, Seminari E, Maggiolo F, Bonora S, Rusconi S, Micheli V, Lo Caputo S, Lazzaroni L, Ferrara S, Ladisa N, Nasta P, Parruti G, Bellagamba R, Forbici F, Angarano G. Saracino A, et al. Among authors: bellagamba r. Curr HIV Res. 2009 Jul;7(4):425-33. doi: 10.2174/157016209788680525. Curr HIV Res. 2009. PMID: 19601778 Free article.
Telemedicine During COVID-19 Pandemic: Lesson Learned from the Lazio Region Infectious Diseases and Emergency Department Network.
Maffongelli G, Bevilacqua N, Vita S, Bartoli TA, Corpolongo A, Benvenuto D, Chiriaco T, Spiga G, Ribaldi S, Zirretta V, Ippolito G, Lauria FN, Vaia F, Nicastri E; COVID Group of the Lazio Region; Bed Manager Group at INMI Spallanzani. Maffongelli G, et al. J Med Syst. 2022 Dec 7;46(12):105. doi: 10.1007/s10916-022-01887-z. J Med Syst. 2022. PMID: 36473993 Free PMC article.
Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.
Tozzi V, Zaccarelli M, Narciso P, Trotta MP, Ceccherini-Silberstein F, De Longis P, D'Offizi G, Forbici F, D'Arrigo R, Boumis E, Bellagamba R, Bonfigli S, Carvelli C, Antinori A, Perno CF. Tozzi V, et al. Among authors: bellagamba r. J Infect Dis. 2004 May 1;189(9):1688-95. doi: 10.1086/382960. Epub 2004 Apr 13. J Infect Dis. 2004. PMID: 15116307 Clinical Trial.
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir.
Trotta MP, Bonfigli S, Ceccherini-Silberstein F, Bellagamba R, D'Arrigo R, Soldani F, Zaccarelli M, Concetta Bellocchi M, Lorenzini P, Marconi P, Boumis E, Forbici F, Comandini UV, Tozzi V, Narciso P, Federico Perno C, Antinori A. Trotta MP, et al. Among authors: bellagamba r. J Med Virol. 2006 May;78(5):535-41. doi: 10.1002/jmv.20573. J Med Virol. 2006. PMID: 16555278
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment.
Aquaro S, D'Arrigo R, Svicher V, Perri GD, Caputo SL, Visco-Comandini U, Santoro M, Bertoli A, Mazzotta F, Bonora S, Tozzi V, Bellagamba R, Zaccarelli M, Narciso P, Antinori A, Perno CF. Aquaro S, et al. Among authors: bellagamba r. J Antimicrob Chemother. 2006 Oct;58(4):714-22. doi: 10.1093/jac/dkl306. Epub 2006 Aug 5. J Antimicrob Chemother. 2006. PMID: 16891628
Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome.
Tozzi V, Zaccarelli M, Bonfigli S, Lorenzini P, Liuzzi G, Trotta MP, Forbici F, Gori C, Bertoli A, Bellagamba R, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of HIV Genotype Resistance Test. Tozzi V, et al. Among authors: bellagamba r. Antivir Ther. 2006;11(5):553-60. Antivir Ther. 2006. PMID: 16964822
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimens.
Nicastri E, Palmisano L, Sarmati L, D'Ettorre G, Parisi S, Andreotti M, Buonomini A, Pirillo FM, Narciso P, Bellagamba R, Vullo V, Montano M, Di Perri G, Andreoni M. Nicastri E, et al. Among authors: bellagamba r. Curr HIV Res. 2008 May;6(3):261-6. doi: 10.2174/157016208784325010. Curr HIV Res. 2008. PMID: 18473790
Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAART.
Tozzi V, Bellagamba R, Castiglione F, Amendola A, Ivanovic J, Nicastri E, Libertone R, D'Offizi G, Liuzzi G, Gori C, Forbici F, D'Arrigo R, Bertoli A, Salvatori MF, Capobianchi MR, Antinori A, Perno CF, Narciso P. Tozzi V, et al. Among authors: bellagamba r. AIDS Res Hum Retroviruses. 2008 Jun;24(6):787-96. doi: 10.1089/aid.2007.0236. AIDS Res Hum Retroviruses. 2008. PMID: 18507523
127 results